Jul 13, 2006

Crackdown triggers pharma's PR spend

The Research and Development Pharmaceutical Association of China (RDPAC) has selected Powell Tate Weber Shandwick to run a positioning campaign as the Central Government widens a national crackdown on corruption and bribery.

RDPAC is an industry body representing 38 foreign pharma companies from the US, Europe and Japan. "RDPAC has been working on programmes aimed at increasing the professionalism of the industry, which also includes codes of conduct and ethics," said John Russell, Weber Shandwick's China-based EVP for Asia-Pacific.

According to Russell, Powell Tate Weber Shandwick, a joint consultancy consisting of healthcare and public affairs specialists, won the business after a pitch which included Ruder Finn, Ogilvy PR, APCO and Blue Focus.

Russell said that while the consultancy was still working with RDPAC to determine the best way to position the association, the pitch was sparked by the Government's moves to reform the healthcare sector in China, which would have significant implications for pharma companies. He added that the brief includes a significant amount of Government outreach along with media relations.

Crackdown triggers pharma's PR spend

The Research and Development Pharmaceutical Association of China (RDPAC) has selected Powell Tate Weber Shandwick to run a positioning campaign as the Central Government widens a national crackdown on corruption and bribery.

RDPAC is an industry body representing 38 foreign pharma companies from the US, Europe and Japan. "RDPAC has been working on programmes aimed at increasing the professionalism of the industry, which also includes codes of conduct and ethics," said John Russell, Weber Shandwick's China-based EVP for Asia-Pacific.

According to Russell, Powell Tate Weber Shandwick, a joint consultancy consisting of healthcare and public affairs specialists, won the business after a pitch which included Ruder Finn, Ogilvy PR, APCO and Blue Focus.

Russell said that while the consultancy was still working with RDPAC to determine the best way to position the association, the pitch was sparked by the Government's moves to reform the healthcare sector in China, which would have significant implications for pharma companies. He added that the brief includes a significant amount of Government outreach along with media relations.

Source:
Campaign Asia
Tags

Related Articles

Just Published

13 hours ago

Spikes Asia unveils its 2024 Creativity Report

This year's top agencies include VML in Melbourne, Ogilvy in Mumbai, Dentsu in Tokyo, and more.

15 hours ago

Creative Minds: Zosia Ella Kilpatrick's quest for ...

An active surfer, a weekend gardener and a wellness enthusiast, the award-winning MullenLowe creative shares secrets to inner peace.

16 hours ago

'Why should I worry about benchmarking against ...

Exclusive: Marketing agency R K Swamy's chairman and MD Srinivasan Swamy delves into the details of the company's pioneering IPO listing in India, and why he's focused on where to invest next in tech.

18 hours ago

Agency Report Cards 2023: We grade 31 APAC networks

Campaign Asia-Pacific presents its 21st annual evaluation of APAC agency networks based on their 2023 business performance, innovation, creative output, awards, action on DEI and sustainability, and leadership.